Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Stallion India Fluorochemicals Ltd

₹ 245-5.00%
05 Jan – close price
🔗stallionfluorochemicals.com•BSE: 544342•NSE: STALLION
Market Cap₹ 1,942 Cr.
Current Price₹ 245
High / Low₹ 424
Stock P/E43.3
Book Value₹ 40.1
Dividend Yield0.00 %
ROCE19.7 %
ROE15.2 %
Face Value₹ 10.0
Sales₹ 453 Cr.
OPM13.9 %
Mar Cap₹ 1,942 Cr.

ABOUT

Incorporated in 2002, Stallion India Fluorochemicals Limited is engaged in selling Refrigerant and Industrial Gases and related products.[1]

KEY POINTS

Business Overview[1]Stallion India Fluorochemicals Limited specializes in manufacturing and distributing refrigerants and specialty gases. With nearly two decades of expertise, the company blends Hydrofluorocarbons (HFCs) and Hydrofluoroolefins (HFOs) for applications across industries such as semiconductors, automotive, electronics, pharmaceuticals, fire extinguishment systems, and aerosol production.

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsRevenue GuidanceAsset Base ExpansionCapacity Expansion And ProductsPreferential IssuanceJv Partnerships AcquisitionsRevenue Guidance Vs ActualsRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.Linde India5927.5099.9150549.720.08169.0161.90644.191.5416.902413.0136.53505.97169.0112.798.990.02
2.Ellen.Indl.Gas329.4053.184642.420.0036.7223.8489.17-5.8518.23312.4835.1580.2236.725.0410.570.13
3.Refex Industries259.7020.323561.250.1936.1941.07426.85-0.2720.892136.5110.44175.3046.542.6612.190.14
4.Stallion India244.8143.311941.960.0011.421243.53105.5656.2519.67452.7513.9044.8411.426.1112.120.00
5.Hilltone Softwar85.00–92.910.00-0.71-745.453.4565.072.349.21-13.79-1.26-0.716.30-0.960.03
6.Natl. Oxygen83.00–41.850.007.049.246.37-39.96-21.5433.35-12.05-7.52-1.08–-21.51–
7.Gagan Gases21.7782.009.840.00-0.01-112.501.6515.3810.645.423.690.12-0.013.047.160.12
–Median: 4 Co.294.5548.254101.840.0436.4551.48266.210.6418.951294.6324.52127.7641.635.5811.340.07

Quarterly Results

Standalone figures in ₹ crores

Dec 2024Jun 2024Jun 2025Mar 2025Sep 2024Sep 2025
Sales
857311015268106
Expenses
7161961336690
Operating Profit
14121419216
Other Income
000200
Profit before tax
12111418115
Tax %
20%26%25%27%-56%25%
Net Profit
1081013111
EPS in Rs
1.591.371.311.670.141.44

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
118186226233377453
Expenses
104153208209330390
Operating Profit
143318244863
Other Income
10-2322
Interest
011464
Depreciation
122111
Profit before tax
133013224260
Net Profit
102110153245
EPS in Rs
8.0417.231.772.524.086.01
Dividend Payout %
0%0%0%0%0%–

Compounded Profit Growth

10 Years:%
5 Years:%
3 Years:15%
TTM:109%

Compounded Sales Growth

10 Years:%
5 Years:%
3 Years:27%
TTM:62%

Return on Equity

10 Years:%
5 Years:%
3 Years:16%
Last Year:15%

Stock Price CAGR

10 Years:%
5 Years:%
3 Years:%
1 Year:%

Balance Sheet

Standalone figures in ₹ crores

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
121255617979
Reserves
28491664222239
Borrowings
102186521
Other Liabilities
104353793034
Total Liabilities
15398126200334353
Fixed Assets
191813141721
Gross Block
20.1921.4917.2219.1823.44–
Accumulated Depreciation
1.373.164.345.456.62–
CWIP
000005
Investments
000000
Other Assets
13480113186316328
Total Assets
15398126200334353

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
-88-3-73-13
Cash from Investing Activity
-2-1-1312-20
Cash from Financing Activity
12-8167676
Net Cash Flow
2-1-11543

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
2825669111102
Inventory Days
12811380178128
Days Payable
3947646727
Cash Conversion Cycle
1693103282203
Working Capital Days
578262147193
ROCE %
–55%22%18%20%

Shareholding Pattern

Numbers in percentages

Mar 2025Jun 2025Sep 2025
Promoters
67.90%67.90%67.90%
FIIs
3.32%0.47%0.80%
DIIs
4.70%4.75%0.07%
Public
24.08%26.88%31.22%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Stallion India Fluorochemicals Closes Trading Window from April 1, 2026

2nd April 2026, 4:35 am

Neomile Entities Disclose Substantial Shareholding Increase in Stallion India Fluorochemicals Ltd

7th March 2026, 7:06 pm

Stallion India Fluorochemicals Allots 3.67 Crore Shares via Rights Issue

7th March 2026, 12:39 am

Stallion India Fluorochemicals Revises Rights Issue Outcome, Corrects Face Value to Rs. 10

3rd March 2026, 2:11 am

Stallion India Fluorochemicals Approves Rights Issue Share Allotment

3rd March 2026, 12:33 am

Published by Other Websites

External media mentions & references

Indian Markets Crash: Mid/Small Caps Plummet Amid Geopolitical Fears

8th March 2026, 12:50 pm

Stallion India Fluorochemicals Shares Surge to New High on Expansion Plans and Strong Demand Outlook

29th September 2025, 2:10 pm

Indian Equity Indices Close Higher for Second Week; Sigachi, Hindustan Copper, Apollo Micro Systems Lead Breakouts

13th September 2025, 6:15 pm

Stallion India Fluorochemicals to Invest Rs 120 Crore for New Refrigerant Plant in Rajasthan

12th August 2025, 3:09 pm

Stallion India Fluorochemicals: Record Growth Fuels Mega Expansion & Helium Ambitions

News Articles

Editorial & research coverage

Stallion India inks Rajasthan MoU for ₹200cr HFO plant, eyes 35% growth
Stallion India inks Rajasthan MoU for ₹200cr HFO plant, eyes 35% growth
Stallion India Raises Rs 364 Cr Via Rights Issue Amidst Trading Scrutiny
Stallion India Raises Rs 364 Cr Via Rights Issue Amidst Trading Scrutiny
SIFL Seals Dubai Deal for Critical Helium Supply, Fuels High-Tech Growth
SIFL Seals Dubai Deal for Critical Helium Supply, Fuels High-Tech Growth
Stallion India Fluorochemicals Eyes ₹364 Cr Raise Amidst ASM Trading Storm
Stallion India Fluorochemicals Eyes ₹364 Cr Raise Amidst ASM Trading Storm
Stallion India Fluorochemicals: Record Growth Fuels Mega Expansion & Helium Ambitions
Stallion India Fluorochemicals: Record Growth Fuels Mega Expansion & Helium Ambitions

Documents

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

2d - Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended 31st December, 2025.

Closure of Trading Window
Receipt Of Environmental Clearance (EC) For The 10,000 MT R32 Manufacturing Plant Of Stallion India Fluorochemicals Limited At Bhilwara , Rajasthan.

29 Dec - SEIAA Rajasthan granted EC (28-Dec-2025) for 10,000 MTpa R-32 plant, HCl byproduct 46,460 MTpa at Bhilwara.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

24 Nov 2025 - Reaffirms FY26 revenue growth 30–35%; Bhilwara R-32 plant commercial by July 2026; ₹500 crore expected.

Announcement under Regulation 30 (LODR)-Monitoring Agency Report

14 Nov 2025 - MA Q2 report: Rs.3.99cr excess issue expenses; total Rs.7.70cr deviation from Rs.160.73cr IPO.

Annual Reports

Financial Year 2025

(from bse)

Credit Ratings

No credit ratings.

Concalls

Oct 2025

TranscriptPPTRecording

Aug 2025

TranscriptPPT

May 2025

TranscriptPPTRecording

Stock Analysis

Description

Stallion India Fluorochemicals Limited, incorporated in 2002, is engaged in selling Refrigerant and Industrial Gases and related products. The company specializes in manufacturing and distributing refrigerants and specialty gases, blending Hydrofluorocarbons (HFCs) and Hydrofluoroolefins (HFOs) for diverse industrial applications.

Key Growth Triggers

  1. Management guidance projects a 30-35% CAGR for the next three years.
  2. Strategic initiatives include expanding into specialty and semiconductor gas capabilities, investing in liquid helium processing, and establishing new refrigerant debulking/blending facilities.
  3. A significant expansion involves a new R-32 refrigerant gas manufacturing facility in Rajasthan, with an investment of ₹120 Crore, aimed at boosting domestic manufacturing and reducing import dependency.
  4. Focus on backward integration is expected to improve profit margins by 3-4%.

Order Book

Currently no data available for Order Book.

Key Red Flags

  1. The CARE Ratings Q2 FY26 Monitoring Agency Report identified significant deviations in IPO fund utilization, including excess expenditure on issue costs and over-utilization for working capital, totaling ₹7.70 crore.
  2. The report also flagged incorrect classification, commingling of funds, and lack of shareholder approval for these deviations, leading to disagreement with the agency.
  3. Past scrutiny over IPO fund usage noted deviations in working capital and unapproved General Corporate Purpose, with management citing banking errors and oversight.

Key Dates To Watch

  1. Q1 FY26 Earnings Call: August 12, 2025
  2. AGM: September 15, 2025
  3. Board Meeting for Q2/H1 FY25-26 results: October 13, 2025
  4. Investor Conference Call for Q2/H1 FY25-26 results: October 15, 2025
  5. Trading window closure: October 1, 2025, and January 1, 2026.

Corporate Announcements

1st Apr 26
Impact Rating: 6
Stallion India Fluorochemicals has closed its trading window for designated persons from April 01, 2026, through 48 hours after the declaration of its audited financial results for the quarter and fiscal year ending March 31, 2026.
7th Mar 26
Impact Rating: 7
Disclosure filed by Neomile Asset Managers shows Neomile Corporate Advisory and Neomile Growth Fund acquired over 8.99% stake in Stallion India Fluorochemicals, boosting total holding to 12.39%.
6th Mar 26
Impact Rating: -
No description available.
2nd Mar 26
Impact Rating: 7
Stallion India Fluorochemicals Ltd. announced a revised rights issue outcome, correcting the face value of equity shares to Rs. 10. The company allotted over 3.67 crore shares at Rs. 99 per share.
2nd Mar 26
Impact Rating: 8
Stallion India Fluorochemicals' Rights Issue Committee approved the allotment of 3,67,60,483 equity shares at ₹99.00 each, raising approximately ₹36,392.88 lakh (₹363.93 cr).